162 related articles for article (PubMed ID: 9415265)
21. Successful treatment of ophthalmoplegia in acromegaly with the somatostatin analogue SMS 201-995.
van Liessum PA; Pieters GF; Hermus AR; Smals AG; Kloppenborg PW
Neth J Med; 1988 Jun; 32(5-6):289-92. PubMed ID: 2899298
[No Abstract] [Full Text] [Related]
22. Coexistence of ectopic pituitary adenoma and empty sella in a patient with acromegaly : a case report and review of literature.
Hong JF; Ding XH; Wang SS
Neurol India; 2012; 60(3):304-6. PubMed ID: 22824688
[TBL] [Abstract][Full Text] [Related]
23. Pregnancy in women after successful acromegaly treatment, including surgical removal of pituitary adenoma and postoperative therapy using lanreotide acetate.
Teltayev D; Akshulakov S; Ryskeldiev N; Mustafin K; Vyacheslav L
Gynecol Endocrinol; 2017; 33(sup1):50-51. PubMed ID: 29264984
[TBL] [Abstract][Full Text] [Related]
24. Partial surgical removal of growth hormone-secreting pituitary tumors enhances the response to somatostatin analogs in acromegaly.
Colao A; Attanasio R; Pivonello R; Cappabianca P; Cavallo LM; Lasio G; Lodrini A; Lombardi G; Cozzi R
J Clin Endocrinol Metab; 2006 Jan; 91(1):85-92. PubMed ID: 16263832
[TBL] [Abstract][Full Text] [Related]
25. [Therapeutic management of acromegaly].
Metzner C; Hadziselimovic S; Grafe I; Nawroth P; Kasperk C
Med Klin (Munich); 2006 Jan; 101(1):15-23. PubMed ID: 16418810
[TBL] [Abstract][Full Text] [Related]
26. [Analgesic effect of a somatostatin analog, SMS 201-995, on headache associated with tumor of the hypophysis].
Webb SM; Cabezas R; Montañés R; de Leiva A
Med Clin (Barc); 1989 Oct; 93(13):501-2. PubMed ID: 2622243
[TBL] [Abstract][Full Text] [Related]
27. Reduction in sella turcica volume. An effect of long-term treatment with the somatostatin analogue, SMS 201-995, in acromegalic patients.
Lund E; Jørgensen J; Christensen SE; Weeke J; Orskov H; Harris AG
Neuroradiology; 1991; 33(2):162-4. PubMed ID: 2046904
[TBL] [Abstract][Full Text] [Related]
28. Grading of pituitary adenomas in acromegaly. Comparison of light microscopical, immunocytochemical, and clinical data.
Riedel M; Saeger W; Lüdecke DK
Virchows Arch A Pathol Anat Histopathol; 1985; 407(1):83-95. PubMed ID: 3925628
[TBL] [Abstract][Full Text] [Related]
29. [Octreotide-induced sinus bradycardia in a male patient with acromegaly].
Lima-Martínez MM; López-Méndez G; Mangupli R
Endocrinol Nutr; 2013 Oct; 60(8):e7-9. PubMed ID: 23415777
[No Abstract] [Full Text] [Related]
30. Effective treatment of recurrent acromegaly with a long-active somatostatin analogue (sandostatin).
Miranda R; Zárate A; Ruíz Velasco G
Arch Invest Med (Mex); 1988; 19(4):445-8. PubMed ID: 3245759
[No Abstract] [Full Text] [Related]
31. Medical progress: Acromegaly.
Melmed S
N Engl J Med; 2006 Dec; 355(24):2558-73. PubMed ID: 17167139
[No Abstract] [Full Text] [Related]
32. Gamma knife radiosurgery for acromegaly--long-term experience.
Jezková J; Marek J; Hána V; Krsek M; Weiss V; Vladyka V; Lisák R; Vymazal J; Pecen L
Clin Endocrinol (Oxf); 2006 May; 64(5):588-95. PubMed ID: 16649981
[TBL] [Abstract][Full Text] [Related]
33. The effects of somatostatin analogs on biochemical parameters in acromegaly.
Liuzzi A; Marzullo P
J Endocrinol Invest; 2003; 26(8 Suppl):46-9. PubMed ID: 15233212
[No Abstract] [Full Text] [Related]
34. Radiotherapy in acromegaly: a protagonists viewpoint.
Wass JA
Clin Endocrinol (Oxf); 2003 Feb; 58(2):128-31. PubMed ID: 12580924
[No Abstract] [Full Text] [Related]
35. Control of tumor size and disease activity during cotreatment with octreotide and the growth hormone receptor antagonist pegvisomant in an acromegalic patient.
van der Lely AJ; Muller A; Janssen JA; Davis RJ; Zib KA; Scarlett JA; Lamberts SW
J Clin Endocrinol Metab; 2001 Feb; 86(2):478-81. PubMed ID: 11157994
[TBL] [Abstract][Full Text] [Related]
36. Predictors of tumor shrinkage after primary therapy with somatostatin analogs in acromegaly: a prospective study in 99 patients.
Colao A; Pivonello R; Auriemma RS; Briganti F; Galdiero M; Tortora F; Caranci F; Cirillo S; Lombardi G
J Clin Endocrinol Metab; 2006 Jun; 91(6):2112-8. PubMed ID: 16537687
[TBL] [Abstract][Full Text] [Related]
37. Improvement of ventricular arrhythmia by octreotide treatment in acromegalic cardiomyopathy.
Tachibana H; Yamaguchi H; Abe S; Sato T; Inoue S; Abe S; Yamaki M; Kubota I
Jpn Heart J; 2003 Nov; 44(6):1027-31. PubMed ID: 14711197
[TBL] [Abstract][Full Text] [Related]
38. [Relationship between clinical and endocrinological features following transsphenoidal surgery of acromegaly. With special reference to somatomedin-C level].
Osawa M; Kobayashi S; Takemae T; Nakagawa F
Neurol Med Chir (Tokyo); 1988 Mar; 28(3):254-8. PubMed ID: 2457827
[No Abstract] [Full Text] [Related]
39. A follow-up of 130 patients with acromegaly in a single centre.
Bolanowski M; Zatonska K; Kaluzny M; Zielinski G; Bednarek-Tupikowska G; Bohdanowicz-Pawlak A; Daroszewski J; Szymczak J; Podgorski JK
Neuro Endocrinol Lett; 2006 Dec; 27(6):828-32. PubMed ID: 17187024
[TBL] [Abstract][Full Text] [Related]
40. Medical therapy with somatostatin analogues for acromegaly.
Sassolas G
Eur J Endocrinol; 1995 Dec; 133(6):675-7. PubMed ID: 8548050
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]